We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kainos Group Plc | LSE:KNOS | London | Ordinary Share | GB00BZ0D6727 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
27.00 | 3.04% | 915.00 | 909.00 | 913.00 | 913.00 | 889.00 | 893.00 | 160,575 | 16:35:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Prepackaged Software | 382.39M | 48.72M | 0.3871 | 23.51 | 1.12B |
Date | Subject | Author | Discuss |
---|---|---|---|
07/2/2016 08:27 | Jeremy Hunt to outline 'paperless NHS' plans 5 hours ago The government has launched its latest attempt to improve the use of technology in the NHS in England. The aim is to create a paperless service that would be more convenient for patients, and help doctors to provide faster diagnoses. More than £4bn has been set aside for areas such as electronic records and online appointments, prescriptions and consultations... | someuwin | |
05/2/2016 10:13 | The plunging dollar will be good for equities esp helpful to indebted miners and emerging markets imo | cestnous | |
05/2/2016 09:57 | IMPORTANT jobs number in the US will give a direction in the stock market short-term anyway especially to stocks or gold. imo | hazl | |
02/2/2016 15:19 | Interesting to see that Cirdan Imaging was founded by the same bloke who stated Andor Technolgy - which was sold to Oxford Instruments for £170m... Belfast software firm Kainos buys 10% stake in Cirdan Imaging By John Campbell BBC News NI Economics & Business Editor Belfast-based software firm Kainos has bought a 10% stake in Cirdan Imaging, a medical diagnostics company. Kainos will invest £900,000 as part of a fundraising round of £3.5m, led by existing shareholder Kernel Capital. Cirdan Imaging, which is also based in Belfast, has a customer base in the US, Canada, Australia and the Middle East. Kainos envisages that Cirdan Imaging could become an important reseller of its Evolve healthcare software in those territories. High-performance As part of the dealt, Cirdan Imaging has entered into a five-year licensing agreement for Evolve software. Brendan Mooney, the chief executive of Kainos, said the new relationship will "open doors for both businesses, creating interesting new growth opportunities". Cirdan Imaging was founded by Dr Hugh Cormican in 2010. Dr Cormican was also a founder of the Andor Technology firm that makes high-performance digital cameras for use in scientific research. He said the investment in Cirdan Imaging would be used to strengthen its laboratory information software product and grow its customer base. | someuwin | |
01/2/2016 14:12 | IS Solutions PLC (ISL) A similar-ish software company to KNOS put out a very bullish trading update today. | someuwin | |
01/2/2016 14:01 | Two months to year end. | someuwin | |
01/2/2016 13:57 | looks a good deal to me ... it's sure been volatile | hazl | |
01/2/2016 13:08 | might head to support justr below 200p | gucci | |
01/2/2016 12:22 | Macro effects - other stocks are suffering today too... | spong_1 | |
01/2/2016 10:57 | so way it's going south? | hanzoo | |
01/2/2016 10:38 | Kainos Group plc 01 February 2016 ANNOUNCEMENT 1 FEBRUARY 2016 Kainos Group plc ("Kainos" or "the Company") Investment in Cirdan Imaging Limited Kainos Group plc (KNOS), a leading UK-based provider of IT, consulting and software solutions, announced today that it has entered into an agreement to acquire 10% of the share capital of Cirdan Imaging Limited ('Cirdan'), a privately-owned supplier of medical diagnostic hardware and software, creating an enhanced partnership and cross-selling opportunities for both businesses. Kainos will invest GBP0.9 million as part of a Series B fundraising of GBP3.5 million led by Kernel Capital. This follows a significant investment by the Kernel Capital Growth Fund in January 2015. Formed in 2010, Cirdan is headquartered in the UK and also has offices in Canada and Australia. Cirdan designs, manufactures and supplies software & imaging solutions for the acceleration and enhancement of medical diagnosis and addresses the market need for robust scalable 'digital workflow' products for pathology laboratories. In 2013 Cirdan acquired a part of GE Healthcare's business - the ULTRA Laboratory Information System (LIS) - which brought with it a blue chip healthcare customer base in the US, Canada, Australia and the Middle East. The fundraising will enable Cirdan to invest further in the development of the ULTRA product. Kainos' investment will enable the two companies to work closely together for their mutual benefit and it is envisaged that Cirdan could become an important reseller of Kainos' Evolve solution in the US, Canada and Australia. As part of this development, Cirdan has entered into a five year Evolve SaaS agreement carrying an annual license fee and additional potential revenue depending on platform usage. Speaking about the investment, Brendan Mooney, CEO of Kainos, commented: "We are delighted to have made this investment in Cirdan, which is a fast-growing and exciting medical diagnostics business. Cirdan has already established a strong customer base and, by working in tandem, we will be able to promote Kainos' services and products, while helping Cirdan further develop its unique ULTRA proposition. Our close relationship will open doors for both businesses, creating interesting new growth opportunities." Hugh Cormican, CEO of Cirdan, said: "This investment comes at an exciting time for Cirdan as we continue to expand our products into new territories. The funding will be used to strengthen our ULTRA LIS offering and grow our customer base. Kainos Evolve is well established in the healthcare industry and we are confident that this investment will open new revenue streams for both businesses." - ENDS - | someuwin | |
30/1/2016 13:40 | Definitely one for the future IMO! Still very much in BUY territory! | dahhad | |
29/1/2016 15:32 | v volatile this one... Tempted to buy some at this price, having missed it's earlier dip the other day | spong_1 | |
28/1/2016 16:09 | I'd rather they won the contracts without shouting about it! I hold. GLA | napoleon 14th | |
28/1/2016 15:13 | Nice move up. | someuwin | |
28/1/2016 14:11 | Nice post someuwin- nice contract win. Not sure how they allocate this in the accounts- at least it's a substantial 3 contract win. Bear market or not, decided to buy a couple of tranches this afternoon. Thanks again for the find. | chuckster1 | |
28/1/2016 13:18 | Nice find someuwin. Thanks. | cestnous | |
28/1/2016 13:17 | they prefer to use tweeter instead and that should be done before article in press anyway brilliant news PE going down making Taurus happier | hanzoo | |
28/1/2016 12:49 | Yeah agree, company should be RNS'ing this sort of contract activity... | edmate | |
28/1/2016 12:46 | Thanks for posting, someuwin. This contract is worth about 10% of current annual turnover. Would be nice to see more news flow from the company. | mirfield | |
28/1/2016 08:49 | A lower PE? :0) | taurusthebear | |
28/1/2016 08:38 | Good solid company,dividend and recurring revenues,what more could you want? | hazl | |
27/1/2016 11:38 | JAMES HILES JUST BOUGHT 7,368 @ 209.0 | mickypel | |
27/1/2016 08:59 | Nice one Wilk1 | reddave999 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions